Health-related quality of life in adults with low-grade gliomas: a systematic review
-
Published:2022-08-06
Issue:3
Volume:32
Page:625-651
-
ISSN:0962-9343
-
Container-title:Quality of Life Research
-
language:en
-
Short-container-title:Qual Life Res
Author:
Rimmer BenORCID, Bolnykh Iakov, Dutton Lizzie, Lewis Joanne, Burns Richéal, Gallagher Pamela, Williams Sophie, Araújo-Soares Vera, Menger Fiona, Sharp Linda
Abstract
Abstract
Purpose
Low-grade glioma (LGG) patients may face health-related quality-of-life (HRQoL) impairments, due to the tumour, treatment and associated side-effects and prospects of progression. We systematically identified quantitative studies assessing HRQoL in adult LGG patients, for: aspects of HRQoL impacted; comparisons with non-cancer controls (NCC) and other groups; temporal trends; and factors associated with HRQoL.
Methods
MEDLINE, CINAHL, Embase, PubMed, and PsycINFO were systematically searched from inception to 14th September 2021. Following independent screening of titles and abstracts and full-texts, population and study characteristics, and HRQoL findings were abstracted from eligible papers, and quality appraised. Narrative synthesis was conducted.
Results
Twenty-nine papers reporting 22 studies (cross-sectional, n = 13; longitudinal, n = 9) were identified. Papers were largely good quality, though many excluded patients with cognitive and communication impairments. Comparators included high-grade gliomas (HGG) (n = 7); NCCs (n = 6) and other patient groups (n = 3). Nineteen factors, primarily treatment (n = 8), were examined for association with HRQoL. There was substantial heterogeneity in HRQoL instruments used, factors and aspects of HRQoL assessed and measurement timepoints. HRQoL, primarily cognitive functioning and fatigue, in adult LGG patients is poor, and worse than in NCCs, though better than in HGG patients. Over time, HRQoL remained low, but stable. Epilepsy/seizure burden was most consistently associated with worse HRQoL.
Conclusion
LGG patients experience wide-ranging HRQoL impairments. HRQoL in those with cognitive and communication impairments requires further investigation. These findings may help clinicians recognise current supportive care needs and inform types and timings of support needed, as well as inform future interventions.
Funder
Brain Tumour Charity
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference69 articles.
1. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020 GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. 2. Miller, K. D., Ostrom, Q. T., Kruchko, C., Patil, N., Tihan, T., Cioffi, G., Fuchs, H. E., Waite, K. A., Jemal, A., & Siegel, R. L. (2021). Brain and other central nervous system tumor statistics, 2021. CA: A Cancer Journal for Clinicians, 71(5), 381–406. 3. Bauchet, L. (2017). Epidemiology of diffuse low grade gliomas. In Diffuse Low-Grade Gliomas in Adults (pp. 13–53). Springer International Publishing. https://doi.org/10.1007/978-3-319-55466-2_2 4. Dixit, K., & Raizer, J. (2017). Newer Strategies for the Management of Low-Grade Gliomas. Oncology (Williston Park, N.Y.), 31(9), 680–682, 684–685. https://www.scholars.northwestern.edu/en/publications/newer-strategies-for-the-management-of-low-grade-gliomas 5. Claus, E. B., Walsh, K. M., Wiencke, J. K., Molinaro, A. M., Wiemels, J. L., Schildkraut, J. M., Bondy, M. L., Berger, M., Jenkins, R., & Wrensch, M. (2015). Survival and low-grade glioma: The emergence of genetic information. Neurosurgical Focus, 38(1), E6. https://doi.org/10.3171/2014.10.FOCUS12367
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|